Who is sponsoring NCT04936958?

NCT04936958 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT04936958?

Interventions in NCT04936958: patients having had an osteomyelitis since 2017.

What condition does NCT04936958 study?

NCT04936958 studies Osteomyelitis.

Is NCT04936958 still recruiting?

NCT04936958 is currently status unknown. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT04936958

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RETR(Osteomyelitis)

Status unknown Last updated 13 April 2023

What this trial tests

trial testing patients having had an osteomyelitis since 2017 in Osteomyelitis in 50 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
1 May 2024

1 May 2025

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 May 2023
Primary completion	1 May 2024
Estimated completion	1 May 2025
Sites	1 location across France

Drugs / interventions tested

patients having had an osteomyelitis since 2017

Conditions studied

Osteomyelitis — all drugs for Osteomyelitis →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

18 and older, any sex, with Osteomyelitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective study describing the management of osteomyelitis in a referece center, with success and failures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteomyelitis

Currently open trials in the same condition.

NCT06283979 — A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Assoc · Phase 2 · recruiting
NCT07056881 — Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa · recruiting
NCT06526884 — Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC) · NA · active not recruiting
NCT05713149 — Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents · recruiting
NCT03594344 — Additional Hyperbaric Oxygen After Lower Extremity Amputation · NA · recruiting

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04936958 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing